Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

Item
http://www.wikidata.org/entity/Q39943309
Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?Management and outcomes of localized esophageal and gastroesophageal junction cancer in older patients.Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma.Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial.Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer.Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study.Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older.Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older.Minimally invasive esophagectomy is safe and effective following neoadjuvant chemoradiation therapy.
P2860

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.

Item
http://www.wikidata.org/entity/Q39943309
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@en
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@nl
type
label
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@en
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@nl
prefLabel
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@en
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Toxicity and outcomes after ch ...... r in patients age 75 or older.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1442-2050.2009.01014.X
P433
P478
P577
P698
P921